Shanghai RAAS Blood Products Co., Ltd.

Shanghai RAAS Blood Products Co., Ltd.verified

002252.SZ

Price:

$6.44

Market Cap:

$42.75B

Shanghai RAAS Blood Products Co., Ltd. engages in the manufacture and sale of blood products in China. It offers human albumin, human intravenous immunoglobulin, human coagulation factor VIII, human prothrombin complex concentrate, human fibrinogen, human thrombin and human fibrin sealant, human immunoglobulin, hepatitis B immunoglobulin, tetanus immunoglobulin, and rabies immunoglobulin products. It also provides testing services for blood products, vaccines, diagnostic reagents, and testing equipment. The company also exports its products to Southeast Asia and Latin America. Shanghai RAAS Blood Products Co., Ltd. was founded in 1988 and is based in Shanghai, China.

Industry

Biotechnology

IPO Date

2008-06-12

Stock Exchange

SHZ

Ticker

002252.SZ

The Enterprise Value as of December 2025 (TTM) for Shanghai RAAS Blood Products Co., Ltd. (002252.SZ) is 43.65B

According to Shanghai RAAS Blood Products Co., Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 43.65B. This represents a change of -1.71% compared to the average of 44.41B of the last 4 quarters.

Shanghai RAAS Blood Products Co., Ltd. (002252.SZ) Historical Enterprise Value (quarterly & annually)

How has 002252.SZ Enterprise Value performed in the past?

The mean historical Enterprise Value of Shanghai RAAS Blood Products Co., Ltd. over the last ten years is 61.09B. The current 43.65B Enterprise Value has changed 7.05% with respect to the historical average. Over the past ten years (40 quarters), 002252.SZ's Enterprise Value was at its highest in in the December 2016 quarter at 112.75B. The Enterprise Value was at its lowest in in the September 2022 quarter at 32.54B.

Quarterly (TTM)
Annual

Average

61.09B

Median

45.73B

Minimum

36.15B

Maximum

111.17B

Shanghai RAAS Blood Products Co., Ltd. (002252.SZ) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Shanghai RAAS Blood Products Co., Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 110.48%

Maximum Annual Enterprise Value = 111.17B

Minimum Annual Increase = -60.26%

Minimum Annual Enterprise Value = 36.15B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202445.10B-2.71%
202346.35B19.58%
202238.76B-10.34%
202143.23B-9.81%
202047.94B32.60%
201936.15B-5.30%
201838.18B-60.26%
201796.08B-13.58%
2016111.17B3.00%
2015107.94B110.48%

Shanghai RAAS Blood Products Co., Ltd. (002252.SZ) Average Enterprise Value

How has 002252.SZ Enterprise Value performed in the past?

The current Enterprise Value of Shanghai RAAS Blood Products Co., Ltd. (002252.SZ) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

43.40B

5-year avg

44.28B

10-year avg

61.09B

Shanghai RAAS Blood Products Co., Ltd. (002252.SZ) Enterprise Value vs. Peers

How is 002252.SZ’s Enterprise Value compared to its peers?

Shanghai RAAS Blood Products Co., Ltd.’s Enterprise Value is greater than Beijing Tiantan Biological Products Co., Ltd. (30.64B), less than Shanghai Allist Pharmaceuticals Co., Ltd. (43.90B), greater than Hualan Biological Engineering Inc. (26.73B), less than Pharmaron Beijing Co., Ltd. (49.35B), greater than Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (38.93B), less than Chongqing Zhifei Biological Products Co., Ltd. (57.99B), greater than Beijing Tongrentang Co., Ltd (38.18B), greater than Asymchem Laboratories (Tianjin) Co., Ltd. (24.99B), greater than Imeik Technology Development Co.,Ltd. (40.87B), greater than Shanghai Junshi Biosciences Co., Ltd. (37.07B),

Build a custom stock screener for Shanghai RAAS Blood Products Co., Ltd. (002252.SZ) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Shanghai RAAS Blood Products Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Shanghai RAAS Blood Products Co., Ltd. (002252.SZ) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Shanghai RAAS Blood Products Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Shanghai RAAS Blood Products Co., Ltd.'s Enterprise Value?

What is the highest Enterprise Value for Shanghai RAAS Blood Products Co., Ltd. (002252.SZ)?

What is the 3-year average Enterprise Value for Shanghai RAAS Blood Products Co., Ltd. (002252.SZ)?

What is the 5-year average Enterprise Value for Shanghai RAAS Blood Products Co., Ltd. (002252.SZ)?

How does the current Enterprise Value for Shanghai RAAS Blood Products Co., Ltd. (002252.SZ) compare to its historical average?